The Past, Present, and Future of PrEP implementation Among People Who Use Drugs

被引:40
作者
Biello, Katie B. [1 ,2 ,3 ,4 ]
Mimiaga, Matthew J. [4 ,5 ,6 ,7 ]
Valente, Pablo K. [1 ,3 ]
Saxena, Nimish [4 ]
Bazzi, Angela R. [8 ,9 ]
机构
[1] Brown Univ, Sch Publ Hlth, Dept Behav & Social Sci, Providence, RI 02912 USA
[2] Brown Univ, Dept Epidemiol, Dept Behav & Social Sci, Providence, RI 02912 USA
[3] Brown Univ, Ctr Hlth Promot & Hlth Equity, Providence, RI 02912 USA
[4] Fenway Hlth, Fenway Inst, Boston, MA USA
[5] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA
[6] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA
[7] Univ Calif Los Angeles, Ctr LGBTQ Advocacy Res & Hlth, Los Angeles, CA USA
[8] Boston Univ, Sch Publ Hlth, Dept Community Hlth Sci, Boston, MA USA
[9] Univ Calif San Diego, Herbert Wertheim Sch Publ Hlth & Human Longev Sci, San Diego, CA 92103 USA
基金
美国国家卫生研究院;
关键词
PrEP; HIV; Substance use; Stimulants; Opioids; Injection drug use; HIV PREEXPOSURE PROPHYLAXIS; HEPATITIS-C VIRUS; INJECT DRUGS; UNITED-STATES; SUBSTANCE USE; SEXUAL RISK; ANTIRETROVIRAL PROPHYLAXIS; BEHAVIORAL ACTIVATION; OVERDOSE DEATHS; OPIOID USE;
D O I
10.1007/s11904-021-00556-z
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose of review Recent HIV outbreaks among people who use drugs (PWUD) necessitate additional HIV prevention tools. Pre-exposure prophylaxis (PrEP) is highly efficacious yet uptake among PWUD remains exceedingly low. To address multilevel, complex barriers to PrEP use among PWUD, a range of intervention strategies are needed. Recent findings The literature on interventions to optimize PrEP use among PWUD is nascent, comprising small pilots and demonstration projects in early phases of intervention development. Initial studies suggest that structural, healthcare, interpersonal, and individual-level interventions can improve PrEP use for PWUD, and a number of efficacy trials are underway. Future studies are needed to optimize the use of new PrEP modalities (e.g., injectable PrEP), simultaneously target multilevel challenges to PrEP use, and evaluate the integration of PrEP into other service settings and substance use treatment modalities.
引用
收藏
页码:328 / 338
页数:11
相关论文
共 127 条
[71]   Initiation into prescription opioid misuse amongst young injection drug users [J].
Lankenau, Stephen E. ;
Teti, Michelle ;
Silva, Karol ;
Bloom, Jennifer Jackson ;
Harocopos, Alex ;
Treese, Meghan .
INTERNATIONAL JOURNAL OF DRUG POLICY, 2012, 23 (01) :37-44
[72]   A randomized intervention trial to reduce the lending of used injection equipment among injection drug users infected with hepatitis C [J].
Latka, Mary H. ;
Hagan, Holly ;
Kapadia, Farzana ;
Golub, Elizabeth T. ;
Bonner, Sebastian ;
Campbell, Jennifer V. ;
Coady, Micaela H. ;
Garfein, Richard S. ;
Pu, Minya ;
Thomas, Dave L. ;
Thiel, Thelma K. ;
Strathdee, Steffanie A. .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2008, 98 (05) :853-861
[73]   Implementation of pre-exposure prophylaxis at a community pharmacy through a collaborative practice agreement with San Francisco Department of Public Health [J].
Lopez, Maria, I ;
Cocohoba, Jennifer ;
Cohen, Stephanie E. ;
Trainor, Nikole ;
Levy, Montica M. ;
Dong, Betty J. .
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2020, 60 (01) :138-144
[74]   Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis [J].
MacArthur, Georgie J. ;
Minozzi, Silvia ;
Martin, Natasha ;
Vickerman, Peter ;
Deren, Sherry ;
Bruneau, Julie ;
Degenhardt, Louisa ;
Hickman, Matthew .
BMJ-BRITISH MEDICAL JOURNAL, 2012, 345
[75]   Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial [J].
Markowitz, Martin ;
Frank, Ian ;
Grant, Robert M. ;
Mayer, Kenneth H. ;
Elion, Richard ;
Goldstein, Deborah ;
Fisher, Chester ;
Sobieszczyk, Magdalena E. ;
Gallant, Joel E. ;
Van Tieu, Hong ;
Weinberg, Winkler ;
Margolis, David A. ;
Hudson, Krischan J. ;
Stancil, Britt S. ;
Ford, Susan L. ;
Patel, Parul ;
Gould, Elizabeth ;
Rinehart, Alex R. ;
Smith, Kimberly Y. ;
Spreen, William R. .
LANCET HIV, 2017, 4 (08) :E331-E340
[76]   Factors associated with the uptake of and adherence to HIV pre-exposure prophylaxis in people who have injected drugs: an observational, open-label extension of the Bangkok Tenofovir Study [J].
Martin, Michael ;
Vanichseni, Suphak ;
Suntharasamai, Pravan ;
Sangkum, Udomsak ;
Mock, Philip A. ;
Chaipung, Benjamaporn ;
Worrajittanon, Dararat ;
Leethochawalit, Manoj ;
Chiamwongpaet, Sithisat ;
Kittimunkong, Somyot ;
Gvetadze, Roman J. ;
McNicholl, Janet M. ;
Paxton, Lynn A. ;
Curlin, Marcel E. ;
Holtz, Timothy H. ;
Samandari, Taraz ;
Choopanya, Kachit .
LANCET HIV, 2017, 4 (02) :E59-E66
[77]   The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugs [J].
Martin, Michael ;
Vanichseni, Suphak ;
Suntharasamai, Pravan ;
Sangkum, Udomsak ;
Mock, Philip A. ;
Leethochawalit, Manoj ;
Chiamwongpaet, Sithisat ;
Curlin, Marcel E. ;
Na-pompet, Supawadee ;
Warapronmongkholkul, Anchalee ;
Kittimunkong, Somyot ;
Gvetadze, Roman J. ;
McNicholl, Janet M. ;
Paxton, Lynn A. ;
Choopanya, Kachit .
AIDS, 2015, 29 (07) :819-824
[78]   Risk Behaviors and Risk Factors for HIV Infection among Participants in the Bangkok Tenofovir Study, an HIV Pre-Exposure Prophylaxis Trial among People Who Inject Drugs [J].
Martin, Michael ;
Vanichseni, Suphak ;
Suntharasamai, Pravan ;
Sangkum, Udomsak ;
Mock, Philip A. ;
Leethochawalit, Manoj ;
Chiamwongpaet, Sithisat ;
Gvetadze, Roman J. ;
Kittimunkong, Somyot ;
Curlin, Marcel E. ;
Worrajittanon, Dararat ;
McNicholl, Janet M. ;
Paxton, Lynn A. ;
Choopanya, Kachit .
PLOS ONE, 2014, 9 (03)
[79]  
Massachusetts Department of Public Health, 2015, MASS HIV AIDS DAT FA
[80]  
Massachusetts Department of Public Health Bureau of Infectious Disease, 2012, SHIFT EP HIV HEP C I